» Articles » PMID: 17093009

Sudden Cardiac Death in Nephrology: Focus on Acquired Long QT Syndrome

Overview
Date 2006 Nov 10
PMID 17093009
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.

Assimon M, Pun P, Al-Khatib S, Brookhart M, Gaynes B, Winkelmayer W Pharmacoepidemiol Drug Saf. 2022; 31(6):670-679.

PMID: 35285107 PMC: 9064943. DOI: 10.1002/pds.5428.


Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.

Assimon M, Pun P, Wang L, Al-Khatib S, Brookhart M, Weber D JAMA Cardiol. 2021; 7(1):75-83.

PMID: 34668928 PMC: 8756330. DOI: 10.1001/jamacardio.2021.4234.


Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection.

Zhao W, Gandhi N, Affas S, Szpunar S, Mesiha N, Saravolatz L Ann Noninvasive Electrocardiol. 2021; 26(5):e12853.

PMID: 33963634 PMC: 8209870. DOI: 10.1111/anec.12853.


Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease.

Assimon M, Wang L, Pun P, Winkelmayer W, Flythe J J Am Heart Assoc. 2020; 9(13):e015969.

PMID: 32578475 PMC: 7670513. DOI: 10.1161/JAHA.120.015969.


Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.

Assimon M, Brookhart M, Flythe J J Am Soc Nephrol. 2019; 30(4):611-623.

PMID: 30885935 PMC: 6442344. DOI: 10.1681/ASN.2018101032.